Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy and Short-Term Safety of Docosahexaenoic Acid (DHA) and Statin Therapy for Subjects With Coronary Artery Disease or Cardiac Risk Equivalents With Moderate Hypertriglyceridemia (IIb)

NCT00360217 is registered in ClinicalTrials.gov with Maine Center for Lipids and Cardiovascular Health as lead sponsor.

NCT NCT00360217
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00360217 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy and Short-Term Safety of Docosahexaenoic Acid (DHA) and Statin Therapy for Subjects With Coronary Artery Disease or Cardiac Risk Equivalents With Moderate Hypertriglyceridemia (IIb)
Lead sponsor
Maine Center for Lipids and Cardiovascular Health
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2006
Completion date
May 31, 2007
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, coronary risk equivalent, diabetes, hyperlipidemia, hypertriglyceridemia (tg>200<500)